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Abstract. In the presence of cycloheximide (CHX) to 
inhibit protein synthesis, a high concentration of stau- 
rosporine (STS) induces almost all cells in explant cul- 
tures of 8/8 types of newborn mouse organs and 3/3 
types of adult mouse organs to die with the characteris- 
tic features of apoptosis. Eggs and blastomeres also die 
in this way when treated with STS and CHX, although 
they are less sensitive to this treatment than trophecto- 
derm or inner cell mass cells whose sensitivity resem- 
bles that of other developing cells. Human red blood 
cells are exceptional in being completely resistant to 
treatment with STS and CHX. As (STS plus CHX)- 
induced cell deaths have been shown to display the 
characteristic features of programmed cell death 
(PCD), we conclude that all mammalian nucleated cells 
are capable of undergoing PCD and constitutively ex- 
press all the proteins required to do so. It seems that 
the machinery for PCD is in place and ready to run, 
even though its activation often depends on new RNA 
and protein synthesis. 
M 
ANY cells undergo programmed cell death (PCD) 1 
during  normal  animal  development  (Glucks- 
mann,  1951),  and  in  most mammalian tissues 
PCD continues throughout life. Although the mechanism 
of PCD is still uncertain, there is increasing evidence that 
it has been conserved in evolution from nematode worms 
to humans and involves one or more members of the Ced- 
3/IL-l~ converting enzyme (ICE) family of cysteine pro- 
teases (Yuan et al., 1993; for reviews see Thornberry et al., 
1995, and Martin and Green, 1995). 
When many types of mammalian cells are cultured in 
the absence of serum or extracellular signaling molecules, 
they undergo PCD (for review see Raft, 1992). Such find- 
ings have led to the proposal that all nucleated mamma- 
lian cells, except for blastomeres  (Biggers et al.,  1971), 
may require signals from other cells to avoid PCD (Raft, 
1992). This death-by-default mechanism might ensure that 
a cell survives only when and where it is needed, just as the 
dependence on extracellular growth factors for cell prolif- 
eration is thought to ensure that a cell divides only when 
another cell is needed (Baserga, 1985). If extracellular sig- 
nals are required to keep the death program suppressed, 
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then anything that blocks the intracellular signaling path- 
ways activated by such survival factors should induce cells 
to undergo PCD. This was the rationale for our originally 
testing staurosporine (STS), a bacterial alkaloid that is a 
broad spectrum inhibitor of protein kinases (Tamaoki and 
Nakano, 1990), many of which are involved in intracellular 
signaling cascades. As expected, we (Jacobson et al., 1993, 
Ishizaki et al., 1993, Raft et al., 1993, Jacobson et al., 1994, 
Ishizaki et  al.,  1994, 1995)  and  others  (Bertrand  et  al., 
1994) have found that a high concentration of STS induces 
PCD in various cell lines and various types of dissociated 
primary cells in culture. It remains to be determined, how- 
ever, whether it does so by blocking intracellular signaling 
pathways activated by extracellular survival signals. 
Several lines of evidence indicate that the cell death in- 
duced by STS is bona fide PCD: (1) the morphology of the 
dead cells, analyzed by both light and electron microscopy, 
is typical apoptosis (Jacobson et al., 1993; Bertrand et al., 
1994; Jacobson et al., 1994); (2) the sequence of organelle 
changes is characteristic of PCD, with nuclear changes, for 
example, occurring early and plasma membrane integrity 
maintained until late (Jacobson et al., 1994); (3) DNA deg- 
radation, which is thought to be an invariable feature of 
PCD, occurs (Bertrand et al., 1994); (4) overexpression of 
the bcl-2 gene, which suppresses more physiological exam- 
ples of PCD (for review see Reed, 1994), also suppresses 
STS-induced cell death (Jacobson et al.,  1993, 1994); and 
(5) peptide inhibitors of the Ced-3/ICE family of cysteine 
proteases can suppress STS-induced PCD in a wide variety 
of cell  types  (see  accompanying paper).  Although  the 
mechanism by which STS activates the death program is 
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PCD, so STS-induced PCD is not exceptional in this respect. 
In principle, extracellular survival signals could be re- 
quired to prevent either the production or the activation 
of proteins involved in executing the death program. The 
findings that inhibitors of RNA or protein synthesis can 
often suppress or delay PCD originally suggested that cells 
have to make new RNA and protein to undergo PCD and 
provided some of the most compelling original evidence that 
these deaths are suicides, in which the cells participate in 
their own demise (Tata, 1966; Duke and Cohen, 1986; Martin 
et al., 1988; Oppenheim et al., 1990).  More recently, how- 
ever, it has been shown that such inhibitors do not always 
suppress PCD and can even induce it (for review see Martin, 
1993). STS-induced PCD in the cell lines and primary cells 
that have been tested, for example, is enhanced rather than 
suppressed by the protein synthesis inhibitor cycloheximide 
(CHX) and can even occur in the absence of a nucleus (Ja- 
cobson et al., 1994). Moreover, survival signals can inhibit 
PCD in the absence of a nucleus (Jacobson et al., 1994) or 
protein synthesis (Harrington et al., 1994). Such findings sug- 
gest that, in many cell types at least, the proteins required 
to execute the death program are constitutively expressed 
and extracellular survival signals act to prevent the activation 
rather than the production of these proteins. 
Unlike most types of mammalian cells, blastomeres do not 
require extracellular signals  to survive in culture: when cul- 
tured from 1-cell up to 16-cell mouse embryos, they can sur- 
vive and divide in the absence of exogenous proteins or sig- 
naling molecules, even when cultured as isolated single cells 
(Biggers et al., 1971). It is unknown whether blastomeres are 
autonomous for survival because they can keep the death 
program suppressed in the absence of extracellular survi- 
val signals or because they lack a functional death program. 
Here we show that, in the presence of CHX, a high con- 
centration of STS induces PCD in almost all cells in explant 
cultures of all of the rodent organs we have tested, includ- 
ing newborn kidney, lung, muscle, pancreas, liver and skin, 
and adult kidney, lung, and pinna (the extracranial part of 
the ear). We also show that although mouse blastomeres 
and eggs are relatively resistant to STS-induced PCD com- 
pared to other developing cells, they too undergo PCD when 
treated with a very high concentration of STS, in the pres- 
ence or absence of CHX; when blastomeres develop into 
inner cell mass (ICM) and trophectoderm cells, however, 
they acquire the sensitivity to STS-induced PCD that is char- 
acteristic of other developing cells. Human red blood cells, 
by contrast, which lack a nucleus and other organelles, are 
impervious to STS and CHX treatment. These findings sug- 
gest that, with the exception of red blood cells, all mammal- 
ian cells, including blastomeres, are capable of undergoing 
PCD and constitutively express all the proteins required to 
run the death program. 
Materials and Methods 
Animals and Materials 
Sprague-Dawley rats and (Balb/c ×  C57B1/6) F1 mice were purchased from 
Harlan UK Ltd. (Bicester, UK) and maintained in the University College 
London Animal Facility. Outbred PO (Pathology, Oxford) mice were ob- 
tained from the  Animal Facility  in  the  ICRF  Developmental Biology 
Unit. STS was a gift from Dr. H. Nakano, Tokyo Research Laboratories 
(Kyowa Hakko Kogyo Co. Ltd.). Ethidium homodimer and calcein-AM 
were purchased from Molecular Probes, Inc. (Eugene, OR). Cell culture 
media, antibiotics, FCS, terminal deoxynucleotidyl transferase (TdT), and 
TdT  buffer  were  from  GIBCO-BRL  (Gaithersburg,  MD).  Biotin-16- 
dUTP was from Boehringer Mannheim GmbH (Germany), and streptavi- 
din-fluorescein was from Amersham (UK). All other reagents were from 
Sigma Chem. Co. (St. Louis, MO), unless indicated. 
Organ Explant Cultures 
Neonatal rats were  killed  by decapitation and various organs were  re- 
moved and placed in cold L-15 medium; the organs were cut into small 
pieces (~500 p.m on each side) with a hemostat-held blade. Adult and new- 
born (Balb/c x  C57B1/6) F1 mice were killed and their organs removed as 
above; small cylindrical pieces of the organs were obtained using a 2-mm 
punch biopsy needle, except for newborn heart and kidney, which were 
cut in half with a sharp blade. Rat tissues were cultured at 37°C in a 10% 
CO2 incubator on polycarbonate filters (Nucleopore, Pleasanton, CA, 0.81xm 
pore size) floating in the wells of 24-well Falcon culture plates in 700 p~l of 
Dulbecco's Modified Eagle's Medium containing 10% FCS and gentamY- 
cin (DMEM/FCS).  After 48 h, STS (1  ~M) and CHX (10  p.g/ml) were 
added to the appropriate  wells and the cultures continued for an addi- 
tional 18 h. Mouse tissues were cultured on 1% agarose disks (5 mm in di- 
ameter) in 35-mm Falcon bacteriological dishes. The agarose disks (two 
per dish) were preincubated in 500 I~1 of DMEM/FCS for 30 min at 37°C 
in  10%  CO2 before the tissue was added.  After 30-60 min, CHX was 
added to the appropriate dishes to a final concentration of 10 p.g/ml, and 
30 min later, STS was added to the same dishes to a final concentration of 
1 or 10 I~M, and the cultures were continued for 1 or 2 d. We showed pre- 
viously that this concentration of CHX inhibited the incorporation  of 
35S-labeled  methionine and cysteine into proteins in GM701 cells by more 
than 95% (Jacobson et al., 1994). 
Frozen Sections and Propidium Iodide and TUNEL 
Labeling of  Explants 
Both rat and mouse explants were fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffer, pH 7.4, at 4°C for 18-48 h and then cryoprotected in 1 M 
sucrose in the same buffer for  1 d. The tissues were then imbedded in 
OCT compound (Miles, Inc., West Haven, CT), frozen in liquid nitrogen, 
and 6-10 Ixm sections were cut with a Bright cryostat and collected onto 
APES- or gelatin-coated glass slides. The sections were labeled with pro- 
pidium iodide (PI) to visualize all of the nuclei, as previously described 
(Barres et al., 1992).  In some cases they were also labeled by the TdT- 
mediated  dUTP-biotin  nick  end  labeling  (TUNEL)  technique,  as  de- 
scribed by Gavrieli et al. (1992), with some modifications, using streptavi- 
din-fluorescein as previously described (Ishizaki et al., 1994). The sections 
stained with PI alone were examined in a Zeiss Universal fluorescence mi- 
croscope, and the proportion of pyknotic nuclei was counted in represen- 
tative fields. The doubly stained sections were examined in an MRC-1000 
laser-scanning, fluorescence, confocal microscope (Bio-Rad  Labs, Her- 
cules, CA). About 6-12 consecutive 1-1~m optical sections were summed, 
and both the TUNEL and PI images of representative fields were printed 
on a Sony VP860CE printer. The proportion of apoptotic cells was deter- 
mined by counting the TUNEL-positive ceils on the micrographs and di- 
viding by the PI-labeled nuclei in the corresponding micrographs. 
Eggs and Blastomeres 
For experiments on outbred PO blastomeres, oestrous females were se- 
lected by external inspection (Champlin et al.,  1973),  paired  overnight 
with males of proven fertility, and checked for the presence of a vaginal 
plug the next morning. Stages between  the 2-4-cell  and morula were 
flushed from the isolated reproductive tract on the second or third day af- 
ter mating (Hogan et al., 1986). The zona pellucida was dissolved with Ty- 
rode's saline that had been acidified to pH 2.5  with HCl (Nichols and 
Gardner,  1984).  Mornlae were decompacted by incubation in CaE+-free 
OC medium containing 0.2% (wt/vol) ethylene glycol bis-(13-amino ethyl 
ether) N,N,N',N'-tetraacetic acid (Gardner and Nichols, 1991) for 10 min 
at 37°C before being dissociated by gentle pipetting in a  siliconized mi- 
cropipette.  The  isolated  blastomeres were  cultured  in  300-p,1 drops  of 
MTF medium (Lane and Gardner, 1992)  at 37°C for 18 h; in some cases 
STS was present at 1 ixM, in the presence or absence of CHX (10 I~g/ml), 
which was added 30 rain before the STS. 
In experiments on (Balb/c x  C57B1/6) F1 mouse blastomeres, 6-8-wk-old 
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to 8 pm. At noon they were injected  intraperitoneaUy  with five interna- 
tional units (IU) of pregnant mare's serum gonadotropin (PMSG; G-4877, 
Sigma). 48 h later, five IU of human chorionic gonadotropin (hCG; CG-5, 
Sigma) was injected.  For mating, 1-2 injected  female mice were caged over- 
night with one adult male of the same strain. Females that had mated were 
used for the recovery of zygotes or 2-4-cell  embryos, and unmated  fe- 
males were used for the recovery of unfertilized  eggs (Hogan et al., 1986). 
Groups of eggs or 1-4-cell  embryos, with the zona intact,  were cultured in 
300-lxl drops of M6 medium (Hogan et al., 1986) at 37°C for 22-60 h in 5% 
CO2, in the presence or absence of STS (10 IxM) or STS plus CHX (10 p,g/ml). 
Cell  viability  was assessed by staining with the vital  dye bisbenzimide 
(HOECHST 33342)  (4  p,g/ml),  which labels the  nucleus, calcein-AM 
(2.5  tJ.M), which  labels  the  cytoplasm of live  cells,  and  ethidium  ho- 
modimer (4 wM), which labels the nucleus in cells in which plasma mem- 
brane integrity has been lost,  as previously described  (Jacobson et al., 
1994). The cells  were examined in an Olympus OMT2 inverted fluores- 
cence microscope at a final magnification of 400. 
In the cases where TUNEL labeling was used, the embryos were trans- 
ferred to PBS containing 1 mg/ml polyvinyl pyrollidone (PBS/PVP) on sil- 
iconized  watch glasses. An equal volume of 4% paraformaldehyde in 0.1 M 
phosphate buffer (PB), containing 1 mg/ml PVP was added, and the em- 
bryos were incubated for 10 min at room temperature followed by two 
washes in PBS/PVP.  The embryos were then incubated for 15 min at room 
temperature in 0.5%  pronase (nuclease-free,  Calbiochem, San Diego, CA) 
in PBS/PVP to remove the zona and washed twice in PBS/PVP, at which 
point most of the embryos broke apart into single blastomeres. The blas- 
tomeres were transferred to poly-L-lysine  (PLL)--coated 13-mm glass cov- 
erslips and fixed  with 4% paraformaldehyde in 0.1  M PB for 30 min at 
room temperature. They were then washed once in distilled  water, al- 
lowed to dry, and then stored dry at -20°C until TUNEL staining, as de- 
scribed above. 
Blastocysts and Inner Cell Mass 
Blastocysts were recovered from timed pregnant outbred mice and the 
zona pellucida was removed with acidified  Tyrode's saline. ICMs were ob- 
tained  from blastocysts by immunosurgery (Solter and  Knowles, 1975; 
Nichols and Gardner, 1984). In brief, after removal of the zona, the blasto- 
cysts were allowed to recover for I h at 37°C in a-medium containing 10% 
FCS. They were rinsed in PBS and then PB plus FCS, and were then incu- 
bated in heat-inactivated rabbit anti-mouse antiserum (diluted 1:9 in PB) 
for 45 min at 37°C. They were rinsed three times for I min each in PB plus 
FCS and then incubated in rat complement (diluted 1:9 in PB) for 8 min at 
37°C. The blastocysts were then transferred to a-medium containing 10% 
FCS for at least 45 min at 37°C to recover, before being gently pipetted to 
remove the lysed trophectoderm from the intact ICM. The zonaless blas- 
tocysts or isolated  inner cell  masses were cultured in  a-medium in the 
presence or absence of 1 IxM STS, or 1 p,M STS plus 10 v.g/ml CHX, at 
37°C in 5% COz in Sterilin bacteriological plastic dishes for 18 h. Cell via- 
bility was assessed as for blastomeres. 
Human Red Blood Cells 
About 20 Ixl of human blood was obtained by finger prick and washed once 
in PBS containing 0.5 mM EDTA and once in DMEM. The red blood cells 
were counted in a haemocytometer and 2 ×  106 cells were cultured in 2 ml 
DMEM/FCS, either alone or with 10 p~M STS or 10 p,M STS plus 10 I~g/ml 
CHX, in 35-mm Falcon tissue culture dishes at 37°C in 10% CO2 for up to 
2 wk. The cells were examined with phase contrast optics in an inverted 
Nikon TMA microscope. 
Results 
Neonatal Organs 
In initial experiments, small pieces of neonatal rat kidney, 
liver, lung, heart, muscle, small intestine, or skin were cul- 
tured on floating polycarbonate filters for 48 h in DMEM/ 
FCS, before STS was added to a final concentration of 1 v,M. 
After an additional 24 h, the explants were fixed in formal- 
dehyde, cut into frozen sections, and stained with propid- 
ium iodide (PI) to visualize the nuclei. In all cases, most of 
the cells in the STS-treated explants had a pyknotic, and 
often fragmented nucleus, whereas fewer than 20% of the 
cells in untreated explants were pyknotic (not shown). 
We then tested similar explants of neonatal mouse heart, 
kidney,  lung,  muscle,  pancreas,  liver or  skin,  either  on 
floating polycarbonate filters or on agarose platforms. In 
these experiments the explants were treated with 1 p~M or 
10 IxM STS in the presence or absence of 10 wg/ml CHX, 
for either 1 or 2 d. The results in all organs were similar. In 
control  cultures  maintained  in  the  absence  of STS  and 
CHX, there were always some cells with a  pyknotic nu- 
cleus, but most of the cells appeared normal. By contrast, 
in cultures treated with 1 or 10 wM STS alone, or with STS 
and CHX, most of the cells had a pyknotic, and sometimes 
fragmented, nucleus. To quantify the PCD induced by STS 
plus CHX, explants were double-labeled by the TUNEL 
technique to detect DNA fragmentation and with PI to vi- 
sualize all the nuclei. The proportions of PI-labeled nuclei 
that were TUNEL-positive were counted in confocal fluo- 
rescence micrographs. In all cases the majority of the nuclei 
in treated explants were TUNEL-positive; only a minority 
of the nuclei in untreated control explants were TUNEL- 
positive. In explants treated with 10 I~M STS and 10 l.Lg/ml 
CHX for 2 d, almost all of the nuclei were TUNEL-posi- 
tive, as shown for representative experiments in Table I 
and Fig. 1. These findings suggest that the great majority 
of the nucleated cells in developing organs are capable of 
undergoing PCD and apparently do not have to make new 
proteins to do so. 
Adult Organs 
To determine whether cells in adult tissues respond simi- 
larly to those in developing tissues, we cultured explants of 
adult mouse kidney, lung and ear pinna on agarose plat- 
forms and treated them as described above for developing 
tissues. Although the cells in the adult tissues were gener- 
Table L (STS + CHX)-induced PCD in Explants of Newborn 
Mouse Organs 
Treatment 
Organ  duration  Staurosporine  PCD 
Heart 
Skin 
Lung 
1  0  37 
"  1  85 
"  10  99 
1  0  26 
"  1  69 
"  10  78 
2  0  41 
"  1  65 
"  10  100 
1  0  22 
"  1  55 
"  10  64 
2  0  31 
"  1  96 
"  10  98 
Pieces of newborn (Balb/c × C57B1/6) FI mouse organs were cultured on agarose 
platforms in DMEM/FCS. In STS-treated explants, CHX was added (to a final con- 
centration of 10 ~g/ml) 30 min before adding the STS. Frozen sections  of the explants 
were double-labeled with PI and by the TUNEL technique, and the proportions  of PI- 
labeled nuclei that were TUNEL-positive were counted in confocal fluorescence mi- 
crographs. Between 300 and 3,000 cells in multiple representative fields were as- 
sessed for each organ and condition. 
Weil et al. Constitutive Expression of  Programmed Cell Death Machinery  1055 Table II. (STS + CHX)-induced PCD in Explants of  Adult 
Mouse Organs 
Treatment 
Organ  duration  Staurosporine  PCD 
d  ~ 
Kidney  1  0  3 
"  10  80 
2  0  31 
"  10  88 
Ear pinna  1  0  10 
"  10  46 
2  0  27 
"  10  70 
Lung  2  0  35 
"  10  100 
Pieces of adult (Balb/c ×  C57B1/6) F1 mouse organs were cultured and assayed as in 
Table I. Between 100 and 1,400 cells in multiple representative fields were assessed 
for each organ and condition. 
Figure 1.  Confocal  fluorescence  micrographs  of (STS  +  CHX)- 
induced PCD in explant cultures of newborn mouse heart (upper 
four panels) and  lung  (lower four panels). The  cultures  were 
treated and processed as in Table I. The heart tissue was cultured 
for 1 d in the presence or absence  of 10 ~M STS and 10 ixg/ml 
CHX, while the lung tissue was cultured for 2 d in the presence or 
absence of 1 ~.M STS and 10 ~g/ml CHX. Bar, 100 i~m. 
ally less sensitive to STS plus CHX than cells in develop- 
ing tissues, when treated with 10 IxM STS in the presence 
of CHX for 2 d, most of the cells had a pyknotic and some- 
times fragmented nucleus,  which was labeled when ana- 
lyzed by the TUNEL technique (Table II). The amount of 
PCD in both control and treated specimens varied across 
the  explant.  In  control  explants,  however,  there  were 
many regions where most of the cells were alive and only 
rare regions where most of the cells were dead; in treated 
cultures, by contrast, there were no regions where most of 
the cells were alive and many regions where almost all of 
the ceils were dead (Fig. 2). The only ceils that seemed re- 
sistant to treatment with STS and CHX were chondrocytes 
in the pinna, but this could be because the drugs failed to 
penetrate the cartilage matrix (see Discussion). Thus, even 
in adult tissues, the majority of nucleated cells seem to be 
capable of undergoing PCD and apparently do not have to 
make new proteins to do so. 
Blastomeres and Eggs 
As mouse blastomeres do not require signals from other 
cells to survive in vitro, it was of interest to test whether they 
could be induced to undergo PCD when treated with STS 
in the presence or absence of CHX. Blastomeres dissoci- 
ated from 2- or 4-cell mouse embryos did not die when cul- 
tured for 18 or 24 h with 1 ~M STS, with or without CHX: 
the cells remained phase-bright, excluded ethidium homo- 
dimer (indicating plasma membrane integrity), had a nor- 
mal looking nucleus when stained with bisbenzimide, and 
were not labeled when analyzed by the TUNEL technique 
(not shown). Blastomeres in intact 4-cell embryos behaved 
similarly, even with 10 I~M STS (Table Ill), as did freshly 
ovulated mouse eggs (not shown). Thus, blastomeres and 
oocytes are unusually resistant to the lethal effects of STS 
and CHX, as all other normal, developing nucleated cell 
types  we  have  tested  undergo  PCD  when  treated  with 
these doses for this time in dissociated-cell culture. 
When eggs or 1-4-cell embryos were treated with 10 p.M 
STS, with or without CHX, for 26-60 h, however, most of 
the cells died (Table III), as judged by their abnormal mor- 
phology when viewed by phase contrast microscopy, their 
failure to fluoresce when exposed to calcein, their staining 
with ethidium homodimer, their pyknotic nucleus visualized 
by bisbenzimide or PI staining, and by their staining when 
labeled by the TUNEL technique  (Fig.  3).  Thus, blasto- 
meres and  eggs seem to be capable of undergoing  PCD 
and do not need to make new proteins to do so. 
Blastocysts 
By the  32-cell stage, mouse blastomeres have developed 
into two distinct cell types, ICM cells, which will give rise to 
the cells of the embryo proper, and trophectoderm cells, 
which will give rise to cells of the  extraembryonic mem- 
branes. When 32--64-cell hlastocysts were treated with 1 ~M 
STS and  10  p~g/ml CHX for 18 h, more than 90%  of the 
cells died with the characteristic morphological features of 
apoptosis (Fig. 4) indicating that both ICM and trophecto- 
derm cells are more sensitive to these agents than are blas- 
tomeres. When isolated ICMs were treated in this way, all 
of the  cells died with  the  features of apoptosis  (Fig.  4). 
Thus,  blastomeres  become more  sensitive  to  (STS  plus 
CHX)-induced PCD after they differentiate into ICM and 
trophectoderm. 
Human Red Blood Cells 
When  human  red  blood cells were  cultured  in  DMEM/ 
FCS  at  106  cells/ml,  they  survived  as  normal-appearing, 
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induced  PCD in explant cultures  of adult mouse pinna. The tis- 
sues were cultured for 2 d and processed as in Table I. STS was 
used at 10 p~M and CHX at 10 Ixg/ml.  Bar, 100 ~m. 
phase-bright, biconcave cells for at least a week. After this 
time, the  cells began to die,  and  all were dead  by 2  wk. 
Dead cells were easily distinguished  as small, phase dark, 
round ghosts. Treatment with 10 IxM STS, with or without 
CHX, had no effect on the morphology or survival of the 
cells (not shown). 
Discussion 
We find that the vast majority of cells in explant cultures 
of 8/8 types of newborn organs and 3/3 types of adult or- 
gans die with the characteristic features of apoptosis when 
treated with high concentrations of STS in the presence of 
CHX. The only cell type that seems to resist this treatment 
is the chondrocyte in explants of adult pinna. It is likely, 
however, that this apparent resistance of the chondrocytes 
reflects the failure of the STS and/or CHX to penetrate the 
extracellular matrix of the cartilage, as we showed previ- 
ously that chondrocytes dissociated from adult rat sternum 
undergo apoptosis when treated in vitro with I  IxM STS for 
1 d  (Ishizaki et al.,  1994).  The requirement for a  higher 
concentration of STS and a longer treatment time for cells 
to undergo PCD in explants of adult organs compared to 
neonatal organs may also reflect differences in drug pene- 
tration.  Taken  together  with  previous  results  obtained 
with various cell lines and dissociated primary cells (see ref- 
erences in Introduction), our present findings suggest that all 
nucleated mammalian cells,  both in developing and mature 
Table III. STS and (STS + CHX)-induced PCD in Mouse 
Embryos and Eggs 
TreaUnent 
Stage  duration  Treatment  Dead/Total  Cell death 
h  % 
4-Cell  22  0  0/99  0 
"  CHX  0•53  0 
"  STS  3/52  6 
"  CHX +  STS  0/48  0 
1-Cell  36  0  0/84  0 
"  CHX  0/22  0 
"  STS  21121  100 
"  CHX +  STS  23/26  89 
2-Cell  37  0  3/46  2 
"  CHX  3/49  6 
"  STS  57158  98 
"  CHX +  STS  47149  96 
4-Cell  36  0  111204  5 
"  CHX  0/56  0 
"  STS  49153  93 
"  CHX +  STS  66169  96 
Egg  28  0  2/42  5 
"  STS  34145  76 
36  CHX  0/24  0 
"  CHX +  STS  22123  96 
Embryos and eggs were flushed from the reproductive tract of mated or unmated su- 
perovulated female (Balb/c ×  C57B1/6)  F1 mice. They were cultured with the zona 
pellucida intact in 300 ttl drops of M6 medium. STS was used at 10 t~M and CHX at 
10-30 ttg/ml. Cell death was indicated by an abnormal morphology when viewed by 
phase-contrast optics, fluorescent staining with ethidium homodimer, lack of calcein 
fluorescence, and nuclear pyknosis visualized by bisbenzimide staining. 
organs, are capable of undergoing PCD and constitutively 
express all of the protein components required  to execute 
the death program. The fact that STS is not a physiological 
inducer of PCD and that we do not know how it activates 
PCD does not affect this conclusion. In those cases where 
inhibitors  of RNA or protein synthesis inhibit PCD, it is 
presumably because macromolecular synthesis is required 
to activate the death program rather than to execute it. 
Even blastomeres and ovulated eggs, both of which are 
relatively resistant to STS treatment, die when the concen- 
tration of STS is increased from I  I~M to 10 IxM and treat- 
ment time is extended from 18-22 h  to 36-60 h, either in 
the  presence or absence of CHX. In the  case of blasto- 
meres, at least, in the  presence or absence of CHX, the 
cells die with the characteristic features of apoptosis, sug- 
gesting that these cells too are capable of undergoing PCD 
and constitutively express the proteins required to execute 
the  death  program.  It seems, therefore,  that  the  reason 
blastomeres do not require extracellular signals to survive 
(Biggers et al., 1971) is not because they lack a functional 
death  program,  but  rather  because  they  can  keep  the 
death program suppressed in the absence of such signals. 
It is likely that eggs are similar to blastomeres in these re- 
spects. Because they are arrested in metaphase of the sec- 
ond meiotic division, however, eggs do not have a discrete 
nucleus,  so it is difficult to  assess whether  the  death  in- 
duced by STS is PCD, although this seems likely. 
When  blastomeres  develop  into  ICM  and  trophecto- 
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(STS  +  CHX)-induced  PCD  in  blastomeres. 
Mouse embryos (4-6 cells) were cultured for 36 h 
in medium alone or STS alone (not shown), or in 
CHX (10 Ixg/ml) or CHX plus STS (10 p,M). The 
zoua pellucida was removed and the btastomeres 
double-labeled  with  PI and  the  TUNEL tech- 
nique as described in Materials and Methods. A 
TUNEL-negative  blastomere  that  was  treated 
with CHX alone is shown in the upper panels. 
Three  TUNEL-positive  blastomeres  that  were 
treated  with  CHX  and  STS  are  shown  in  the 
lower panels.  Blastomeres treated with medium 
alone were also TUNEL-negative. Bar, 25 txm. 
derm, we find that they become just as sensitive to (STS 
plus  CHX)-induced  PCD  as  other  developing  cells.  The 
molecular basis for this change in susceptibility remains to 
be  determined.  The  change in susceptibility is consistent 
with  the  findings  that  substantial  numbers  of ICM,  and 
possibly trophectoderm cells, undergo PCD in normal de- 
velopment  (EI-Shershaby and Hinchliffe,  1974),  whereas 
blastomeres apparently do not. 
Perhaps not surprisingly, mature human erythrocytes do 
not die when treated with  10  I~M STS in the presence or 
Figure 4.  (STS  +  CHX)-induced PCD in blastocysts and ICMs. 
Blastocysts at the 32-64-cell  stage were flushed from the repro- 
ductive tract of timed pregnant PO mice, and the zona pellucida 
was removed with acidified  Tyrode's saline.  ICMs were isolated 
by immunosurgery. The blastocysts and ICMs were cultured in 
a-medium in the presence or absence of 1 I~M STS and 10 ~g/ml 
CHX for 18 h, and cell viability was assessed  as in Table III. 
absence of CHX. Thus far, they are the only mammalian 
cells shown not to do so. These cells lack all organeUes and 
presumably do not have the molecular machinery required 
for PCD. It is not simply the lack of a  nucleus that is re- 
sponsible  for their  resistance,  as anucleate cytoplasts are 
able  to  undergo  PCD  (Jacobson  et  al.,  1994;  Schulze- 
Osthoff et al., 1994; Nakajima et al., 1995). 
Much of what is known about the molecular mechanism 
of PCD came originally from genetic studies of the nema- 
tode C. elegans, which identified two genes, ced-3 and ced-4, 
that are required for all the PCDs that occur during devel- 
opment: if either gene is inactivated by mutation, none of 
these cell deaths occur (Ellis and Horvitz, 1986). Whereas 
ced-4 encodes a  novel protein  (Yuan and Horvitz, 1992), 
ced-3  encodes a  member of the IL-113 converting enzyme 
(ICE) family of cysteine proteases (Yuan et al., 1993). One 
or more members of this family also seem to play impor- 
tant roles in PCD in vertebrate cells: ced-3 and other fam- 
ily members can induce PCD when ectopically expressed 
in mammalian cells (Gagliardini  et al., 1994; Miura et al., 
1993; Wang et  al.,  1994; Fernandes-Alnemri  et  al.,  1994; 
Kumar et al.,  1994), and inhibitors of these proteases can 
inhibit PCD in vertebrate cells (for review see Martin and 
Green,  1995),  including  STS-induced  PCD  (Cain  et  al., 
1995; Mashima et al., 1995; Zhu et al., 1995, and accompa- 
nying paper).  Another  C.  elegans  gene,  ced-9,  acts  as  a 
brake on the death program: when it is inactivated by mu- 
tation, most of the cells in the developing worm undergo 
ced-3-  and  ced-4-dependent  PCD  (Hengartner  et  al., 
1992). The latter finding suggests that ced-3 and ced-4, and 
the  other  genes required  to execute  the  death  program, 
are constitutively expressed in most, and perhaps all, cells 
in the developing worm. It may be, therefore, that consti- 
The Journal of Cell Biology, Volume 133, 1996  1058 tutive expression of the machinery for PCD including the 
relevant members  of Ced-3/ICE family of proteases,  is a 
general feature of animal cells. 
Two novel cell death genes, reaper (White et al., 1994) and 
hid  (Grether  et  al.,  1995),  have  been  identified  in  Dro- 
sophila. A  DNA deletion that eliminates both genes elimi- 
nates all of the PCDs that occur during normal fly devel- 
opment, yet PCD can occur if the mutant flies are exposed 
to a very high dose  of x-rays  (White et al., 1994). Thus, 
these death genes apparently encode proteins that activate 
the  death  program  rather  than  execute  it.  Moreover, 
reaper  is  transcriptionally  activated  1-2  h  before  PCD, 
suggesting  that the  activation  of the death machinery in 
flies  normally  depends  on  RNA  and  protein  synthesis. 
This seems likely to be the case also for many of the nor- 
mal cell deaths that occur in developing vertebrates as well 
(Tata,  1966;  Oppenheim  et  al.,  1990;  Coucouvanis  and 
Martin, 1995), although a homologue of reaper has yet to 
be identified in vertebrates. 
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